Hydroxyzine Should NOT Be Given to Pregnant Women
Hydroxyzine is contraindicated in early pregnancy and should be avoided throughout pregnancy. 1
Primary Recommendation
The FDA drug label explicitly states that hydroxyzine is contraindicated in early pregnancy based on animal studies showing fetal abnormalities in rats and mice at doses above human therapeutic range, and inadequate clinical data to establish safety in humans 1. This represents the strongest level of evidence—a formal contraindication from regulatory authorities.
Clinical Guidelines Alignment
The British Journal of Dermatology guidelines reinforce this position, stating that hydroxyzine is the only antihistamine specifically contraindicated during the early stages of pregnancy in the U.K. manufacturer's Summary of Product Characteristics 2. While the guidelines note that no antihistamine has been proven teratogenic in humans, they emphasize it is best to avoid all antihistamines in pregnancy, especially during the first trimester.
Safer Alternatives When Antihistamine Treatment Is Necessary
If antihistamine therapy is unavoidable during pregnancy:
- Chlorphenamine (chlorpheniramine) is often chosen by U.K. clinicians due to its long safety record 2
- Loratadine and cetirizine are classified as FDA Pregnancy Category B drugs, indicating no evidence of fetal harm (though well-controlled human studies are lacking) 2
Important Caveats
Research Evidence Shows Mixed Picture
One prospective controlled study of 120 pregnancies found no increased teratogenic risk with hydroxyzine or cetirizine exposure 3. However, this research evidence cannot override the FDA contraindication, which is based on the precautionary principle given inadequate human safety data.
Neonatal Withdrawal Risk
A case report documented neonatal seizures associated with maternal hydroxyzine use (150 mg/day) in late pregnancy, suggesting possible withdrawal syndrome 4. This adds another layer of concern beyond teratogenicity.
Lactation Concerns
Hydroxyzine should not be given to nursing mothers, as it is unknown whether the drug is excreted in human milk 1.
Clinical Decision Algorithm
- Is the patient in early pregnancy or planning pregnancy? → Hydroxyzine is contraindicated
- Is antihistamine treatment absolutely necessary? → Choose chlorphenamine, loratadine, or cetirizine instead
- Is the patient breastfeeding? → Avoid hydroxyzine
The risk-benefit analysis does not favor hydroxyzine use at any stage of pregnancy given available safer alternatives.